Congo Begins Trial Of Gilead's Experimental Antiviral for Ebola Bundibugyo
Researchers in the Democratic Republic of Congo said on Tuesday they have started enrolling participants in a trial testing Gilead Sciences' experimental antiviral... Reuters Health Information
Take Your Experience to the Next Level
NewDownload our mobile app for a faster and better experience.
Comments
0U
Join the discussion
Sign in to leave a comment